ME Therapeutics Holdings, Inc. (TSE:METX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
ME Therapeutics Holdings Inc., a Vancouver-based biotech firm specializing in innovative cancer immunotherapies, has announced CEO Dr. Salim Dhanji’s participation in the Bloom Burton & Co. Healthcare Investor Conference and an interview on CSE TV. The conference, which provides a platform for one-on-one investor meetings, will be held in Toronto on April 16-17, 2024. These events mark a strategic effort by ME Therapeutics to increase investor awareness as they continue to progress in the field of myeloid targeted immuno-oncology research.
For further insights into TSE:METX stock, check out TipRanks’ Stock Analysis page.
